| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Omega Therapeutics Inc. Common Stock (NASDAQ: OMGA)
OMGA Technical Analysis
2
| As on 9th Jun 2023 OMGA STOCK Price closed @ 7.87 and we RECOMMEND Buy for LONG-TERM with Stoploss of 6.59 & Strong Sell for SHORT-TERM with Stoploss of 11.81 we also expect STOCK to react on Following IMPORTANT LEVELS. |
OMGASTOCK Price
| Open | 8.19 | Change | Price | % |
| High | 8.35 | 1 Day | -0.26 | -3.20 |
| Low | 7.84 | 1 Week | 0.07 | 0.90 |
| Close | 7.87 | 1 Month | 0.68 | 9.46 |
| Volume | 70700 | 1 Year | -6.21 | -44.11 |
| 52 Week High 15.20 | 52 Week Low 2.01 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| OMGA Daily Charts |
OMGA Intraday Charts |
Whats New @ Bazaartrend |
OMGA Free Analysis |
|
|
OMGA Important Levels Intraday
| RESISTANCE | 8.85 |
| RESISTANCE | 8.54 |
| RESISTANCE | 8.34 |
| RESISTANCE | 8.15 |
| SUPPORT | 7.59 |
| SUPPORT | 7.40 |
| SUPPORT | 7.20 |
| SUPPORT | 6.89 |
OMGA Forecast April 2024
| 4th UP Forecast | 19.03 |
| 3rd UP Forecast | 15.45 |
| 2nd UP Forecast | 13.24 |
| 1st UP Forecast | 11.03 |
| 1st DOWN Forecast | 4.71 |
| 2nd DOWN Forecast | 2.5 |
| 3rd DOWN Forecast | 0.29 |
| 4th DOWN Forecast | -3.29 |
OMGA Weekly Forecast
| 4th UP Forecast | 15.31 |
| 3rd UP Forecast | 12.92 |
| 2nd UP Forecast | 11.45 |
| 1st UP Forecast | 9.97 |
| 1st DOWN Forecast | 5.77 |
| 2nd DOWN Forecast | 4.29 |
| 3rd DOWN Forecast | 2.82 |
| 4th DOWN Forecast | 0.43 |
OMGA Forecast2024
| 4th UP Forecast | 34.48 |
| 3rd UP Forecast | 25.95 |
| 2nd UP Forecast | 20.67 |
| 1st UP Forecast | 15.4 |
| 1st DOWN Forecast | 0.34 |
| 2nd DOWN Forecast | -4.93 |
| 3rd DOWN Forecast | -10.21 |
| 4th DOWN Forecast | -18.74 |
Omega Therapeutics Inc. Common Stock ( NASDAQ USA Symbol : OMGA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
OMGA Business Profile
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-regulate the expression of HNF4a, a transcriptional master regulator as a potential way to restore liver-cell function in patients suffering from chronic liver diseases; to control the expression of genes that have been strongly linked to cell-growth inhibition in patients with diabetes and other conditions to restore the capacity for corneal regeneration; to down-regulate expression of the CXCL1, 2, 3, and IL-8 gene cluster; to control expression of genes implicated in patients with idiopathic pulmonary fibrosis to halt or reverse disease progression and improve disease outcomes; to down-regulate the expression of SFRP1, a protein that inhibits hair growth; and to treat non-small cell lung cancer and small cell lung cancer. It is also developing OTX-2002 to down-regulate c-Myc, an oncogene. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Address: 20 Acorn Park Drive, Cambridge, MA, United States, 02140
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service